Treatment of chronic heart failure in long-term care facilities: implications of recent heart failure guidelines recommendations
Related Experiment Video
Updated: Sep 16, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-2041, USA. aahmed@uab.edu
Insights
Heart failure management guidelines are evolving to include older adults and those with preserved systolic function. This review examines recent guidelines for long-term care facility residents, emphasizing improved evaluation and care.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Angiotensin-converting enzyme inhibitors revolutionized heart failure management but are underutilized.
- Established guidelines primarily focused on systolic dysfunction, overlooking a significant patient population.
- Heart failure is a geriatric syndrome, with many older adults having preserved systolic function.
Purpose of the Study:
- To review the relevance of recent European Society of Cardiology and American College of Cardiology/American Heart Association guidelines.
- To assess the applicability of these guidelines to heart failure patients in long-term care facilities.
- To highlight the need for appropriate evaluation and management of heart failure in aging populations.
Main Methods:
- Review of two major heart failure guidelines published in late 2001.
- Analysis of recommendations for patients with preserved left ventricular systolic function.
- Consideration of special populations, including older adults and those in long-term care.
Main Results:
- Recent guidelines now include recommendations for preserved systolic function and special populations.
- An increasing number of heart failure patients are older adults residing in long-term care facilities.
- These guidelines offer a framework for improving care in this setting.
Conclusions:
- The evolving guidelines are crucial for addressing the needs of older adults with heart failure.
- Effective implementation in long-term care facilities is essential for enhancing patient outcomes.
- Future care must adapt to the demographic shift towards an aging population with complex heart failure needs.
Abstract:
Use of angiotensin-converting enzyme inhibitor in heart failure with left ventricular systolic dysfunction has revolutionized management of heart failure and resulted in several national heart failure guidelines. However, studies have documented underutilization of these life saving drugs. Subsequently, results of other randomized clinical trials revealed the beneficial effects of angiotensin receptor blockers, beta-blockers, and spironolactone in heart failure with systolic dysfunction, which prompted several other guidelines. However, all these guidelines were primarily restricted to systolic dysfunction. Heart failure is as much a geriatric syndrome as it is a cardiac. Most heart failure patients are older adults. About half of the heart failure in older adults is not associated with left ventricular systolic dysfunction. Two recent heart failure guidelines, from the European Society of Cardiology and the American College of Cardiology/American Heart Association, published respectively in September and December 2001 included recommendations for patients with preserved left ventricular systolic function and other special populations, including older adults and those at end of life. The purpose of this article is to review the relevance of these two guidelines to heart failure patients living in long-term care facilities. As our population is aging, more heart failure patients are expected to live in long-term care facilities. Appropriate evaluation and management of these patients are essential to improve quality of heart failure care in the coming decades.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

